A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

Journey of Prescient Therapeutics in 2019

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug

An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy

AFP’s FY19 Performance - What investors need to know?

Kazia Therapeutics collaborates with Alliance to investigate new drug, GDC-0084

GMV executes two Provider Participation Agreements with United States-based companies

Looking Through The Business Model Of This Drug Development Company – Noxopharm

Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited

HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA

HeraMed collaborates with Meerkats for Australian B2C launch

CardieX Limited Provides Interim Corporate Update

Alcidion Group Announces ~$2.1 Mn Deal With Dartford And Gravesham NHS Trust

Australian Pharmaceutical Releases Market Update on API-Sigma Merger Proposal

Opthea Limited Announces the Addition of OPT ticker in All Ordinaries, Effective from March 18, 2019

Zoono Group Announces Proceedings Against Stayzon

Cardiex announced the extension of Atcor Medical’s pharma contract with Bayer Ag

A Shot In The Arm For MGC Pharma, Independent Laboratory Test Validates Proprietary Genetic Strains!

Auscann Appointed Mr Ido Kanyon As Its CEO – Stock Zoomed Up By 2.353%